STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease
Clinical trial NCT05843578 · COMPLETED
Trial details
- NCT number
- NCT05843578
- Sponsor
- Agomab Spain S.L.U.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2026-06-20
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.